Loading chat...
NY S02722
Bill
Status
4/24/2017
Primary Sponsor
Jeffrey Klein
Click for details
AI Summary
-
Defines "controlled substance analogue" as a substance with chemical structure substantially similar to Schedule I or II controlled substances that produces similar or greater stimulant, depressant, or hallucinogenic effects on the central nervous system.
-
Establishes that controlled substance analogues are deemed equivalent to their parent controlled substances for all legal purposes under New York law.
-
Excludes from the definition: actual controlled substances, substances with FDA-approved new drug applications, and substances with valid FDA investigational use exemptions.
-
Modifies the definition of "knowingly" for analogue-related offenses to not require knowledge of chemical structure, only that the person knew or should have known of the substance's psychoactive effects or represented it as such.
-
Takes effect immediately upon passage.
Legislative Description
Provides that a controlled substance analogue shall be deemed to be the controlled substance to which it is substantially similar or mimics.
Last Action
COMMITTED TO RULES
6/20/2018